HomeCompareBAX vs MPLX

BAX vs MPLX: Dividend Comparison 2026

BAX yields 2.28% · MPLX yields 7.47%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MPLX wins by $430.1K in total portfolio value
10 years
BAX
BAX
● Live price
2.28%
Share price
$15.80
Annual div
$0.36
5Y div CAGR
-27%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$10.26
Full BAX calculator →
MPLX
MPLX
● Live price
7.47%
Share price
$57.67
Annual div
$4.31
5Y div CAGR
38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$450.7K
Annual income
$220,593.13
Full MPLX calculator →

Portfolio growth — BAX vs MPLX

📍 MPLX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBAXMPLX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BAX + MPLX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BAX pays
MPLX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BAX
Annual income on $10K today (after 15% tax)
$193.67/yr
After 10yr DRIP, annual income (after tax)
$8.72/yr
MPLX
Annual income on $10K today (after 15% tax)
$635.25/yr
After 10yr DRIP, annual income (after tax)
$187,504.16/yr
At 15% tax rate, MPLX beats the other by $187,495.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BAX + MPLX for your $10,000?

BAX: 50%MPLX: 50%
100% MPLX50/50100% BAX
Portfolio after 10yr
$235.7K
Annual income
$110,301.69/yr
Blended yield
46.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MPLX right now

BAX
Analyst Ratings
15
Buy
20
Hold
1
Sell
Consensus: Hold
Price Target
$19.75
+25.0% upside vs current
Range: $15.00 — $25.00
Altman Z
2.1
Piotroski
5/9
MPLX
Analyst Ratings
19
Buy
9
Hold
Consensus: Buy
Price Target
$59.50
+3.2% upside vs current
Range: $59.00 — $60.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BAX buys
0
MPLX buys
0
No recent congressional trades found for BAX or MPLX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBAXMPLX
Forward yield2.28%7.47%
Annual dividend / share$0.36$4.31
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-27%38.1%
Portfolio after 10y$20.6K$450.7K
Annual income after 10y$10.26$220,593.13
Total dividends collected$602.00$402.2K
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusHoldBuy
Analyst price target$19.75$59.50

Year-by-year: BAX vs MPLX ($10,000, DRIP)

YearBAX PortfolioBAX Income/yrMPLX PortfolioMPLX Income/yrGap
1← crossover$10,866$166.33$11,732$1,032.10$866.00MPLX
2$11,750$123.31$14,116$1,562.81$2.4KMPLX
3$12,664$90.97$17,531$2,426.93$4.9KMPLX
4$13,617$66.89$22,649$3,890.12$9.0KMPLX
5$14,619$49.07$30,720$6,486.35$16.1KMPLX
6$15,679$35.94$44,226$11,355.22$28.5KMPLX
7$16,802$26.30$68,420$21,098.77$51.6KMPLX
8$17,998$19.23$115,338$42,128.55$97.3KMPLX
9$19,272$14.05$215,071$91,658.85$195.8KMPLX
10$20,631$10.26$450,719$220,593.13$430.1KMPLX

BAX vs MPLX: Complete Analysis 2026

BAXHealthcare

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesion prevention; and continuous renal replacement therapies and other organ support therapies focused in the intensive care unit. It also provides connected care solutions, including devices, software, communications, and integration technologies; integrated patient monitoring and diagnostic technologies to help diagnose, treat, and manage a various illness and diseases, including respiratory therapy, cardiology, vision screening, and physical assessment; surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. In addition, the company offers contracted services to various pharmaceutical and biopharmaceutical companies. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

Full BAX Calculator →

MPLXEnergy

MPLX LP owns and operates midstream energy infrastructure and logistics assets primarily in the United States. It operates in two segments, Logistics and Storage, and Gathering and Processing. The company is involved in the gathering, processing, and transportation of natural gas; gathering, transportation, fractionation, exchange, storage, and marketing of natural gas liquids; gathering, storage, transportation, and distribution of crude oil and refined products, as well as other hydrocarbon-based products; and sale of residue gas and condensate. It also engages in the inland marine businesses comprising transportation of light products, heavy oils, crude oil, renewable fuels, chemicals, and feedstocks in the Mid-Continent and Gulf Coast regions, as well as owns and operates boats and barges, including third-party chartered equipment, and a marine repair facility located on the Ohio River; and distribution of fuel, as well as operates refining logistics, terminals, rail facilities, and storage caverns. In addition, the company operates terminal facilities for the receipt, storage, blending, additization, handling, and redelivery of refined petroleum products located through the pipeline, rail, marine, and over-the-road modes of transportation. MPLX GP LLC acts as the general partner of MPLX LP. The company was incorporated in 2012 and is headquartered in Findlay, Ohio. MPLX LP operates as a subsidiary of Marathon Petroleum Corporation.

Full MPLX Calculator →
📬

Get this BAX vs MPLX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BAX vs SCHDBAX vs JEPIBAX vs OBAX vs KOBAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.